$30.48
-1.49 (-4.66%)
Performance
1D
—
1W
-1.61%
1M
+0.76%
3M
-3.48%
6M
-16.74%
1Y
+20.86%
YTD
-37.31%
Open$31.72
Previous Close$31.97
Day High$32.16
Day Low$30.27
52W High$56.05
52W Low$23.05
Volume—
Avg Volume1.50M
Market Cap2.42B
P/E Ratio—
EPS$-5.86
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$31.83
Below
SMA 200
$36.73
Below
RSI (14)
62.6
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+210.4% upside
Current
$30.48
$30.48
Target
$94.61
$94.61
$72.50
$94.61 avg
$144.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 672.08M | 640.49M | 736.20M |
| Net Income | -5,512,106 | -4,610,660 | -5,991,019 |
| Profit Margin | -0.8% | -0.7% | -0.8% |
| EBITDA | -7,633,568 | -6,751,763 | -9,172,286 |
| Free Cash Flow | -4,482,853 | -2,925,974 | -4,789,156 |
| Rev Growth | +20.0% | +11.6% | +0.9% |
| Debt/Equity | 0.79 | 0.70 | 0.90 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |